Scientist Who Received Millions From NIH Leaves Alabama Posts

An investigation finds 20 papers by Santosh Katiyar, who studied alternative treatments for cancer, include image manipulation.

Written byIvan Oransky and Retraction Watch
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Santosh KatiyarVA RESEARCH CURRENTSA professor who received about $5 million in grants from the National Institutes of Health left his posts at the University of Alabama, Birmingham (UAB), and Birmingham VA Medical Center last year after an investigation found evidence of image manipulation in 20 of his papers, Retraction Watch has learned.

Since March 30, five articles by Santosh Katiyar that explore alternative approaches to treating skin cancer in animal models have been retracted as a result of the institutions’ probe.

The university and medical center requested a total of 20 papers be retracted, according to UAB research integrity officer Pam Bounelis. “Certain published images within those papers were not substantiated by available data, or the scientific conclusions of the publication were not supported,” Bounelis tells Retraction Watch. “Dr. Katiyar’s employment at UAB was ended on May 1, 2017.”

In an email, Bounelis says a journal alerted UAB to concerns about Katiyar's work in 2012 and the university began looking into the allegations then. UAB declined to share a copy of the report of the investigation.

Four ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies